Kymera Therapeutics, Inc.
NASDAQKymera Therapeutics enters its May 7 earnings call with two forces pulling in opposite directions: short sellers have been cutting exposure for six weeks, yet options traders are more defensively positioned than they have been in months. The short retreat is the more striking move. Short interest as a percentage of free float peaked near 19.1% in early April and has since dropped…
Snapshot as of 7 May 2026
Kymera Therapeutics enters its May 7 earnings call with two forces pulling in opposite directions: short sellers have been cutting exposure for six weeks, yet options traders are more defensively positioned than they…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for KYMR — free to start on ORTEX.
Sign up for free →Open KYMR on ORTEX